REGN three-lens brief
Evidence-based stock research on REGN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $878.31 — 17% above current (28 analysts). · Debt-to-equity of 9.5 — balance-sheet-heavy.
- Analyst mean target $878.31 — 17% above current (28 analysts).
- Debt-to-equity of 9.5 — balance-sheet-heavy.
REGN closed at $751.57 (-1.89%) as of 2026-04-25. Market cap: $79.46B. P/E (trailing) 18.1. Positives: analyst mean target $878.31 — 17% above current (28 analysts).. Concerns: debt-to-equity of 9.5 — balance-sheet-heavy.. Last quarter: Revenue $3.88B, net income $844.60M, free cash flow $3.26B.
Why three lenses on REGN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine REGNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/REGN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath REGN brief"></iframe>